4.7 Review

Mechanisms of pruritus in cholestasis: understanding and treating the itch

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

Marlyn J. Mayo et al.

Summary: This study investigated the impact of pruritus on quality of life and its management in patients with PBC. The prevalence of pruritus was found to be high and it had a negative impact on patients' quality of life. However, the study also found that pruritus in PBC is often undertreated.

DIGESTIVE DISEASES AND SCIENCES (2023)

Article Gastroenterology & Hepatology

Symptom patterns in the daily life of PSC patients

Kim N. van Munster et al.

Summary: This study aimed to assess the daily symptoms and patterns in PSC patients and found that pruritus and fatigue are prevalent symptoms in their daily life, showing a distinct diurnal pattern. The severity of pruritus is highly correlated with day temperature, which may have implications for the dosing of anti-pruritic agents.

LIVER INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

Disease burden and management of Crigler-Najjar syndrome: Report of a world registry

Sem J. Aronson et al.

LIVER INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on sclerosing cholangitis

European Assoc Study Liver

Summary: This article presents guidelines for the management of primary or secondary sclerosing cholangitis, covering topics such as diagnostic methods, prognostic assessment, early detection of complications, optimal care pathways, and therapeutic options for both adults and children.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Use of Butorphanol as Treatment for Cholestatic Itch

Rachel Shireen Golpanian et al.

Summary: Butorphanol is a potential treatment option for cholestatic pruritus, showing clinically significant symptomatic improvement in some patients. However, it is associated with side effects such as somnolence, sedation, nausea, vomiting, and dizziness, indicating the need for further studies to better understand its effects on cholestatic itch.

DIGESTIVE DISEASES AND SCIENCES (2021)

Review Physiology

MOLECULAR PHYSIOLOGY OF BILE ACID SIGNALING IN HEALTH, DISEASE, AND AGING

Alessia Perino et al.

Summary: Bile acids have become important signaling molecules in the body, enabling inter-tissue communication and exerting pleiotropic physiological effects. The chemical variety of bile acids, largely determined by the gut microbiome, allows for complex adaptive responses in the body. This review discusses the mechanisms by which bile acid receptors coordinate various aspects of physiology and presents new therapeutic strategies for diseases related to pathological bile acid signaling.

PHYSIOLOGICAL REVIEWS (2021)

Article Gastroenterology & Hepatology

Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial

Elsemieke de Vries et al.

Summary: The study demonstrated the efficacy of bezafibrate in improving moderate to severe pruritus in patients with PSC and PBC, suggesting a potential role in reducing hepatobiliary injury.

GASTROENTEROLOGY (2021)

Article Biochemistry & Molecular Biology

Inhibition of autotaxin by bile salts and bile salt-like molecules increases its expression by feedback regulation

Jacqueline A. G. M. Langedijk et al.

Summary: Experimental studies have shown that multiple biliary compounds accumulate during cholestasis can increase ATX expression levels by inhibiting ATX activity, thereby significantly enhancing ATX activity. This mechanism may help explain the increased serum ATX activity in patients with cholestasis.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Article Obstetrics & Gynecology

A multi-centre, open label, randomised, parallel-group, superiority Trial to compare the efficacy of URsodeoxycholic acid with RIFampicin in the management of women with severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC randomised trial

William M. Hague et al.

Summary: Severe early onset intrahepatic cholestasis of pregnancy (ICP) affects 0.1% of pregnant women in Australia, with limited treatment options such as ursodeoxycholic acid (UDCA) and rifampicin. This study will be the first to examine the outcomes of treatment specifically in the severe early onset form of ICP, comparing the efficacy of rifampicin and UDCA, providing high-quality evidence for rifampicin use.

BMC PREGNANCY AND CHILDBIRTH (2021)

Article Obstetrics & Gynecology

Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study

A. L. Mitchell et al.

Summary: Non-fasting bile acids can improve the diagnostic accuracy of intrahepatic cholestasis of pregnancy (ICP) diagnosis, with variations in non-fasting TSBA reference ranges among different ethnicities.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2021)

Article Gastroenterology & Hepatology

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH

Rohit Loomba et al.

Summary: In patients with bridging fibrosis and cirrhosis, 48 weeks of treatment with cilofexor/firsocostat was well tolerated and resulted in improvements in NASH activity, potentially having an antifibrotic effect. This combination offers potential for fibrosis regression with longer-term therapy in patients with advanced fibrosis attributable to NASH.

HEPATOLOGY (2021)

Review Medicine, General & Internal

Cholestasis-Associated Pruritus and Its Pruritogens

Jacqueline A. G. M. Langedijk et al.

Summary: This article discusses the debilitating symptom of pruritus in various cholestatic disorders, the unresolved molecular mechanisms, and the current guidelines-approved therapy. Experimental therapeutic approaches are also necessary to improve patients' quality of life.

FRONTIERS IN MEDICINE (2021)

Article Gastroenterology & Hepatology

Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine

Yong Chen et al.

Summary: The study identified LPC as a novel pruritogen in cholestatic liver diseases, causing itch through epithelia-sensory neuron cross talk. This finding provides a new perspective for the treatment of itch.

GASTROENTEROLOGY (2021)

Editorial Material Gastroenterology & Hepatology

FXR agonists for NASH: How are they different and what difference do they make?

Claus Kremoser

JOURNAL OF HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Reduced spontaneous itch in mouse models of cholestasis

Jacqueline Langedijk et al.

Summary: In this study, researchers found that scratch activity decreased rather than increased in cholestatic mice and wild type mice under cholestasis conditions, indicating that increased plasma ATX activity does not necessarily lead to exacerbated scratching behavior. This raises doubts about the suitability of mice for studying cholestatic itch perception.

SCIENTIFIC REPORTS (2021)

Review Gastroenterology & Hepatology

Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis

Caroline Ovadia et al.

Summary: The study found that ursodeoxycholic acid treatment had no significant effect on the prevalence of stillbirth in women with intrahepatic cholestasis of pregnancy, but when considering only randomized controlled trials, ursodeoxycholic acid was associated with a reduction in stillbirth in combination with preterm birth, providing evidence for the clinical benefit of antenatal ursodeoxycholic acid treatment.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Pediatrics

Clinical features of sodium-taurocholate cotransporting polypeptide deficiency in pediatric patients: case series and literature review

Ting-Ting Zou et al.

Summary: Sodium-taurocholate cotransporting polypeptide (NTCP) deficiency is a newly reported hereditary bile acid metabolic disease, presenting most commonly with jaundice in pediatric patients. It can be detected during routine check-ups and is characterized by hypercholanemia and elevated AST. Screening for c.800C>T mutation in SLC10A1 is useful for primary genetic screening in Chinese infants with persistent hypercholanemia after infectious, structural, and immunological factors are excluded.

TRANSLATIONAL PEDIATRICS (2021)

Article Gastroenterology & Hepatology

Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study

Robin Erken et al.

Summary: Vonafexor, as a FXR agonist, was found to be safe in chronic hepatitis B patients with a potential anti-viral effect observed through a decline in HBV markers. Larger trials are needed to further evaluate its therapeutic potential.

JOURNAL OF VIRAL HEPATITIS (2021)

Article Gastroenterology & Hepatology

Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study

Ulrich Baumann et al.

Summary: Orally administered Odevixibat was well tolerated and effectively reduced serum bile acids, improving pruritus and sleep disturbance in pediatric patients with cholestatic diseases.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2021)

Letter Gastroenterology & Hepatology

Reply to: UDCA therapy in intrahepatic cholestasis of pregnancy?

Ulrich Beuers et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Obeticholic acid for the treatment of nonalcoholic steatohepatitis

Raj A. Shah et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis

Maren H. Harms et al.

JOURNAL OF HEPATOLOGY (2019)

Article Multidisciplinary Sciences

MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus

James Meixiong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Gastroenterology & Hepatology

Ursodeoxycholic acid in pregnancy?

Elsemieke de Vries et al.

JOURNAL OF HEPATOLOGY (2019)

Article Medicine, General & Internal

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

C. Corpechot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Gastroenterology & Hepatology

Effects of Bezafibrate on Outcome and Pruritus in Primary Biliary Cholangitis With Suboptimal Ursodeoxycholic Acid Response

Anna Reig et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield et al.

JOURNAL OF HEPATOLOGY (2017)

Letter Endocrinology & Metabolism

NTCP deficiency and persistently raised bile salts: an adult case

Filip Van Herpe et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2017)

Article Gastroenterology & Hepatology

Apical Sodium-Dependent Transporter Inhibitors in Primary Binary Cholangitis and Primary Sclerosing Cholangitis

Vinod S. Hegade et al.

DIGESTIVE DISEASES (2017)

Article Gastroenterology & Hepatology

The safety and efficacy of nasobiliary drainage in the treatment of refractory cholestatic pruritus: a multicentre European study

V. S. Hegade et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Medicine, Research & Experimental

Evidence for the involvement of nitric oxide in cholestasis-induced itch associated response in mice

Sattar Ostadhadi et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Multidisciplinary Sciences

Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling

Willem-Jan Keune et al.

NATURE COMMUNICATIONS (2016)

Article Obstetrics & Gynecology

Rifampicin in the treatment of severe intrahepatic cholestasis of pregnancy

Victoria Geenes et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2015)

Review Gastroenterology & Hepatology

New paradigms in the treatment of hepatic cholestasis: From UDCA to FXR, PXR and beyond

Ulrich Beuers et al.

JOURNAL OF HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Autotaxin activity has a high accuracy to diagnose intrahepatic cholestasis of pregnancy

Andreas E. Kremer et al.

JOURNAL OF HEPATOLOGY (2015)

Article Biochemistry & Molecular Biology

Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate

Matthew G. K. Benesch et al.

JOURNAL OF LIPID RESEARCH (2015)

Editorial Material Gastroenterology & Hepatology

NTCP deficiency: A new inherited disease of bile acid transport

Serge Erlinger

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)

Review Biochemistry & Molecular Biology

Receptors, cells and circuits involved in pruritus of systemic disorders

Andreas E. Kremer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Gastroenterology & Hepatology

The Bile Acid Receptor TGR5 Activates the TRPA1 Channel to Induce Itch in Mice

TinaMarie Lieu et al.

GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

Pruritus in Cholestasis: Facts and Fiction

Ulrich Beuers et al.

HEPATOLOGY (2014)

Article Medicine, Research & Experimental

The TGR5 receptor mediates bile acid-induced itch and analgesia

Farzad Alemi et al.

JOURNAL OF CLINICAL INVESTIGATION (2013)

Review Medicine, General & Internal

Interventions for treating cholestasis in pregnancy

Vinita Gurung et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

Article Physiology

Bile Formation and Secretion

James L. Boyer

COMPREHENSIVE PHYSIOLOGY (2013)

Article Gastroenterology & Hepatology

Efficacy of Ursodeoxycholic Acid in Treating Intrahepatic Cholestasis of Pregnancy: A Meta-analysis

Yannick Bacq et al.

GASTROENTEROLOGY (2012)

Article Dermatology

The Itch of Liver Disease

Nora V. Bergasa

SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2011)

Article Gastroenterology & Hepatology

Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus

Andreas E. Kremer et al.

GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Liver disease associated with canalicular transport defects: Current and future therapies

Janneke M. Stapelbroek et al.

JOURNAL OF HEPATOLOGY (2010)

Review Gastroenterology & Hepatology

Primary Biliary Cirrhosis

Keith D. Lindor et al.

HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

Ulrich Beuers et al.

JOURNAL OF HEPATOLOGY (2009)

Review Pharmacology & Pharmacy

Pathogenesis and Treatment of Pruritus in Cholestasis

Andreas E. Kremer et al.

Article Biochemistry & Molecular Biology

Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development

Laurens A. van Meeteren et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Review Gastroenterology & Hepatology

Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis

Ulrich Beuers

NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy

J Kondrackiene et al.

GASTROENTEROLOGY (2005)

Article Pharmacology & Pharmacy

Itch-scratch responses induced by lysophosphatidic acid in mice

T Hashimoto et al.

PHARMACOLOGY (2004)

Review Gastroenterology & Hepatology

Ursodeoxycholic acid - adverse effects and drug interactions

W Hempfling et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)

Review Medicine, General & Internal

Bile acids and progesterone metabolites in intrahepatic cholestasis of pregnancy

H Reyes et al.

ANNALS OF MEDICINE (2000)